Perimenopause & Menopause, a Holistic Look at Moving Through an Inevitable & Necessary Transition

In this episode we take a look at the hot topic that is Perimenopause & Menopause and drill deeper than the estrogen/progesterone story to investigate what might be causing common symptoms as well at looking at ways to naturally support women through this transition.Support my workbuymeacoffee.com/angelmunroBook in a session with mehttps://www.angel-munro.com/serviceshttps://www.angel-munro.com/wholefood-suplements-herbs https://www.angel-munro.com/first-aidhttps://www.angel-munro.com/post/castor-oil-the-how-why-easy-at-home-remedyReferencesAson, B., Armah, F. A., & Essumang, D. K. (2022). Characterization and quantification of endocrine disruptors in female menstrual blood samples. Toxicology Reports, 9, 1877–1882. https://doi.org/10.1016/j.toxrep.2022.10.007Clark, M. L., Burch, J. B., Yost, M. G., Cragin, L. A., Fitzpatrick, C. T. E., Bachand, A. M., Ramaprasad, J., & Reif, J. S. (2006). Residential Radiofrequency Exposure and Estrogen Production Among Pre- And Postmenopausal Women. Epidemiology, 17(6), S436. https://journals.lww.com/epidem fulltext/2006/11001residential_radiofrequency_exposure_and_estrogen.1168.aspxKirk, A. B., Michelsen-Correa, S., Rosen, C., Martin, C. F., & Blumberg, B. (2021). PFAS and Potential Adverse Effects on Bone and Adipose Tissue Through Interactions With PPARγ. Endocrinology, 162(12), bqab194. https://doi.org/10.1210/endocr/bqab194Meneguzzi, A., Fava, C., Castelli, M., & Minuz, P. (2021). Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence. Frontiers in Endocrinology, 12, 706352. https://doi.org/10.3389/fendo.2021.706352Neff, A. M., Laws, M. J., Warner, G. R., & Flaws, J. A. (2022). The Effects of Environmental Contaminant Exposure on Reproductive Aging and the Menopause Transition. Current Environmental Health Reports, 9(1), 53–79. https://doi.org/10.1007/s40572-022-00334-yTrémollieres, F. A., Pouilles, J. M., & Ribot, C. (2001). Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 12(5), 385–390. https://doi.org/10.1007/s001980170107Upson, K., Shearston, J. A., & Kioumourtzoglou, M.-A. (2022). An epidemiologic review of menstrual blood loss as an excretion route for per- and polyfluoroalkyl substances. Current Environmental Health Reports, 9(1), 29–37. https://doi.org/10.1007/s40572-022-00332-0